Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 30;22(19):10606. doi: 10.3390/ijms221910606

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effect of empagliflozin in the kidney. (A) Relative weight is expressed as the weight of kidneys related to 100 g of body weight. (B) Microalbuminuria was assessed as albumin/creatinine ratio in urine sample. (C) Changes of mRNA level of selected genes involved in inflammatory and injury processes in the kidney cortex. (D) Changes of mRNA level of selected genes involved in glucose metabolism in the kidney cortex. Control group (n = 7) and empagliflozin group (n = 8). Empagliflozin group received a standard diet enriched by 0.01% empagliflozin for 6 weeks. Data are expressed as mean ± SEM; * p ˂ 0.05; ** p ˂ 0.01; *** p ˂ 0.001.